Kyverna Therapeutics OverviewKyverna Therapeutics Net Income
Profitability analysis for KYTX.
Quarterly Net Income
-$39.73M
↑ 10.99% YoY
As of Mar 2026
Annual Net Income (TTM)
-$156.40M
↓ 7.55% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...